NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

AZTA

Azenta Inc

Jun 30 • 04:00PM ET

30.78

Dollar change +0.19
Percentage change 0.62	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DHR ILMN TMO A BIO HOLX WAT CTLT QGEN MMS

| Held by: IJR VTI VB IWM VXF VBR ROBO SPSM IWN DFAT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.41	Insider Own	2.12%	Shs Outstand	45.78M	Perf Week	5.66%
Market Cap	1.41B	Forward P/E	39.72	EPS next Y	0.78	Insider Trans	0.01%	Shs Float	44.81M	Perf Month	12.62%
Enterprise Value	1.13B	PEG	-	EPS next Q	0.13	Inst Own	116.18%	Short Float	10.30%	Perf Quarter	-11.07%
Income	-65.36M	P/S	2.22	EPS this Y	4.88%	Inst Trans	1.68%	Short Ratio	4.69	Perf Half Y	-38.75%
Sales	633.80M	P/B	0.83	EPS next Y	80.23%	ROA	-1.70%	Short Interest	4.62M	Perf YTD	-38.44%
Book/sh	37.17	P/C	4.26	EPS next 5Y	35.97%	ROE	-2.00%	52W High	63.58 -51.59%	Perf Year	-43.11%
Cash/sh	7.22	P/FCF	54.41	EPS past 3/5Y	- -	ROIC	-3.72%	52W Low	23.91 28.73%	Perf 3Y	-57.42%
Dividend Est.	-	EV/EBITDA	31.66	Sales past 3/5Y	8.51% -3.41%	Gross Margin	40.31%	Volatility	4.57% 4.18%	Perf 5Y	-28.99%
Dividend TTM	-	EV/Sales	1.79	EPS Y/Y TTM	48.51%	Oper. Margin	-6.15%	ATR (14)	1.29	Perf 10Y	152.50%
Dividend Ex-Date	Dec 02, 2021	Quick Ratio	2.84	Sales Y/Y TTM	-2.76%	Profit Margin	-10.31%	RSI (14)	59.33	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.22	EPS Q/Q	64.17%	SMA20	3.70%	Beta	1.63	Target Price	30.20
Payout	-	Debt/Eq	0.03	Sales Q/Q	-9.88%	SMA50	10.14%	Rel Volume	0.98	Prev Close	30.59
Employees	3300	LT Debt/Eq	0.03	Earnings	May 07 BMO	SMA200	-23.99%	Avg Volume	985.03K	Price	30.78
IPO	Feb 02, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-28.57% 1.80%	Trades		Volume	963,491	Change	0.62%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-18-24	Upgrade	Stephens	Equal-Weight → Overweight	$50 → $60
Apr-04-24	Initiated	Jefferies	Hold	$64
Feb-01-24	Reiterated	B. Riley Securities	Buy	$61 → $79
Jul-19-23	Initiated	Raymond James	Mkt Perform
May-10-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-09-23	Downgrade	Stephens	Overweight → Equal-Weight	$65 → $60
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line	$60 → $62
Mar-31-22	Resumed	B. Riley Securities	Buy	$106
Mar-21-22	Initiated	Evercore ISI	Outperform	$100

Jun-02-25 12:02AM	3 Reasons to Sell AZTA and 1 Stock to Buy Instead (StockStory)
May-13-25 04:05PM	Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development (PR Newswire)
May-08-25 03:11AM	Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... (GuruFocus.com) +9.70%
May-07-25 01:45PM	Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 (Seeking Alpha)
01:44PM	Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript (Seeking Alpha)
09:35AM	Loading…
09:35AM	Netflix Investors Unfazed by Tariffs With Growth Engine Humming (Bloomberg)
06:30AM	Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 (PR Newswire)
Apr-29-25 09:01AM	2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution (StockStory)
Apr-24-25 04:15PM	Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast (PR Newswire) +5.16%
Apr-17-25 09:31AM	Azenta: Life Science Business Failing To Come To Life (Seeking Alpha)
Mar-27-25 05:13AM	3 Reasons AZTA is Risky and 1 Stock to Buy Instead (StockStory)
Mar-24-25 04:05PM	Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report (PR Newswire)
Mar-10-25 05:05PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum (PR Newswire) -6.62%
Feb-05-25 08:23AM	Azentas (NASDAQ:AZTA) Q4 Sales Top Estimates (StockStory)
07:00AM	Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 (PR Newswire)
03:59PM	Loading…
Feb-04-25 03:59PM	Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently? (Insider Monkey)
Jan-30-25 04:05PM	Azenta Announces the Election of Dipal Doshi to its Board of Directors (PR Newswire)
Jan-27-25 04:05PM	Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-23-25 04:05PM	UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence (PR Newswire)
Nov-29-24 01:00AM	Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks (TipRanks)
Nov-19-24 05:56PM	Flex Set to Join SandP MidCap 400; Azenta and Concentra Group Holdings to Join SandP SmallCap 600 (PR Newswire) +9.14%
05:56PM	Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 (PR Newswire)
Nov-14-24 08:00AM	Azenta to Participate in Stephens Annual Investment Conference (PR Newswire)
Nov-13-24 02:17AM	Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 04:05PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO (PR Newswire)
Nov-04-24 04:05PM	Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire) +8.93%
08:00AM	Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value (PR Newswire)
Oct-30-24 04:05PM	Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test (PR Newswire)
Sep-04-24 08:00AM	AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO (PR Newswire)
Aug-12-24 04:05PM	GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event (PR Newswire)
04:05PM	Loading…
Aug-06-24 04:05PM	Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 (PR Newswire) -8.93%
Aug-05-24 04:05PM	Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-24-24 04:05PM	Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-24 04:05PM	FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study (PR Newswire) +8.10%
Jun-04-24 04:05PM	Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research (PR Newswire)
May-23-24 04:05PM	Azenta to Participate in the Jefferies Global Healthcare Conference (PR Newswire)
May-14-24 06:34AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Robotics Stocks (InvestorPlace)
May-13-24 04:46PM	Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK (PR Newswire)
May-10-24 01:07PM	Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges (GuruFocus.com)
May-09-24 12:53PM	Azenta, Inc. (NASDAQ:AZTA) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 08:58PM	AZTA Stock Earnings: Azenta Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:06PM	Azenta Announces CEO Succession Plan (PR Newswire)
04:05PM	Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 (PR Newswire)
May-01-24 04:05PM	Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast (PR Newswire)
Apr-25-24 11:28AM	11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-01-24 04:15PM	Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report (PR Newswire)
04:05PM	Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-12-24 08:00AM	Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum (PR Newswire)
Feb-08-24 10:53AM	Azenta, Inc. (NASDAQ:AZTA) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-07-24 05:02PM	Azenta Inc (AZTA) Faces Revenue Decline and EPS Drop in Q1 Fiscal 2024 (GuruFocus.com)
04:05PM	Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023 (PR Newswire)
Feb-02-24 08:00AM	Azenta Launches the BioArc Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management (PR Newswire)
Jan-25-24 04:05PM	Azenta Announces Fiscal 2024 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-11-24 04:05PM	Azenta to Host Investor Day on March 14, 2024 (PR Newswire)
Jan-09-24 04:05PM	Azenta to Participate in the 26th Annual Needham Growth Conference (PR Newswire)
Jan-03-24 04:05PM	Azenta to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Nov-21-23 04:05PM	Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference (PR Newswire)
Nov-14-23 01:06PM	Azenta, Inc. (NASDAQ:AZTA) Q4 2023 Earnings Call Transcript (Insider Monkey) +13.89%
Nov-13-23 05:04PM	Azenta Inc (AZTA) Reports Revenue Growth in Q4 and FY 2023 Despite Earnings Pressure (GuruFocus.com)
04:07PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023 (PR Newswire)
04:06PM	Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation (PR Newswire)
04:05PM	Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project (PR Newswire)
Nov-10-23 04:05PM	Azenta to Participate in the Stephens Annual Investment Conference (PR Newswire)
Nov-08-23 04:05PM	Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire)
Oct-19-23 04:05PM	Azenta to Host GENEWIZ Week November 6-10, 2023 (PR Newswire)
Sep-26-23 08:00AM	Azenta Announces CFO Transition (PR Newswire)
Sep-08-23 04:05PM	Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (PR Newswire)
Sep-07-23 04:05PM	Azenta to Participate in the Baird 2023 Global Healthcare Conference (PR Newswire)
Aug-10-23 08:00AM	Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 (PR Newswire)
Aug-09-23 04:05PM	Azenta to Participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1X1 Conference (PR Newswire) +20.33%
12:00PM	Azenta (NASDAQ:AZTA) lifts 4.0% this week, taking five-year gains to 70% (Simply Wall St.)
Aug-08-23 04:05PM	Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023 (PR Newswire)
Aug-03-23 04:05PM	Azenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jun-29-23 04:05PM	Azenta Announces New Biorepository in the Greater Boston Area (PR Newswire)
Jun-21-23 08:00PM	AZTA: Lowering target price to $36.00 (Argus Research)
May-31-23 10:24AM	Vazyme Signs Global Strategic Cooperation Agreement with Azenta (PR Newswire)
May-30-23 04:05PM	Azenta to Participate in the Jefferies Healthcare Conference (PR Newswire)
May-24-23 08:00AM	Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery (PR Newswire)
May-17-23 04:05PM	Azenta to Participate in the 23rd Annual B. Riley Securities Institutional Investor Conference (PR Newswire) +5.53%
May-09-23 04:05PM	Azenta Reports Results of Second Quarter of Fiscal 2023 and Announces Business Realignment (PR Newswire) -18.89%
May-03-23 04:05PM	Azenta Announces Fiscal 2023 Second Quarter Earnings Conference Call and Webcast (PR Newswire)
Apr-26-23 08:00PM	AZTA: Lowering target price to $43.00 (Argus Research)
Apr-13-23 07:00PM	Azenta to Participate in the 22nd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-15-23 05:06PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (PR Newswire)
Mar-07-23 04:15PM	Azenta Publishes its Environmental, Social, & Governance (ESG) Report (PR Newswire)
Feb-28-23 04:05PM	Azenta to Participate in Upcoming Investor Conferences (PR Newswire)
Feb-27-23 07:30AM	Azenta Launches Cryo Store Pico, a Novel Automated Cryogenic Storage System Designed for Clinical and Laboratory Applications (PR Newswire)
Feb-10-23 07:30AM	Azenta to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (PR Newswire)
Feb-08-23 04:05PM	Azenta Reports First Quarter Results For Fiscal 2023, Ended December 31, 2022 (PR Newswire) -18.29%
Feb-06-23 04:35PM	Azenta Announces Fiscal 2023 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Feb-03-23 07:00AM	Azenta Announces the Acquisition of Ziath (PR Newswire)
Jan-23-23 09:00AM	Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors (GlobeNewswire)
Jan-05-23 08:00AM	Azenta to participate in the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
07:55AM	Azenta to participate in the 25th Annual Needham Growth Conference (PR Newswire)
Dec-22-22 11:21AM	Should You Consider Azenta (AZTA) for Investment? (Insider Monkey)
Nov-23-22 07:15AM	Azenta Announces $500 Million Accelerated Share Repurchase Agreement (PR Newswire)
Nov-21-22 04:05PM	Azenta to participate in the 5th Annual Evercore ISI HealthCONx Conference (PR Newswire)
Nov-14-22 04:10PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program (PR Newswire) +21.83%
04:09PM	Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors (PR Newswire)
Nov-09-22 08:30AM	Azenta to participate in the Stephens Annual Investment Conference (PR Newswire)

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hughes Violetta	VP, Chief Accounting Officer	Feb 03 '25	Sale	52.97	317	16,791	9,603	Feb 04 04:10 PM
Zhou Ginger	SVP and General Manager, Genom	Jan 31 '25	Buy	45.88	417	19,132	27,916	Feb 04 04:10 PM
Pirogova Olga	SVP and CHRO	Nov 19 '24	Sale	40.07	548	21,958	19,373	Nov 21 04:10 PM
Hughes Violetta	VP, Chief Accounting Officer	Nov 19 '24	Sale	40.07	163	6,531	9,920	Nov 21 04:10 PM
Zhou Ginger	SVP and General Manager, Genom	Nov 19 '24	Sale	40.07	491	19,674	27,499	Nov 21 04:10 PM
Wang David Dong	SVP & GM, SMS	Nov 19 '24	Sale	40.07	348	13,944	24,114	Nov 21 04:10 PM
Joseph Jason	SVP, General Counsel, Secy.	Nov 19 '24	Sale	40.07	1,139	45,640	112,564	Nov 21 04:10 PM
Cueto Herman	EVP, Chief Financial Officer	Nov 19 '24	Sale	40.07	712	28,530	23,892	Nov 21 04:10 PM
Marotta John	President and CEO	Nov 18 '24	Buy	39.48	12,717	502,066	99,612	Nov 19 04:10 PM
Marotta John	President and CEO	Nov 19 '24	Buy	40.67	1,250	50,838	100,862	Nov 19 04:10 PM
Cornog William L	Director	Nov 18 '24	Buy	39.60	12,500	495,000	14,755	Nov 19 04:10 PM
HIRSCH DIDIER	Director	Nov 18 '24	Buy	39.50	1,000	39,500	3,465	Nov 19 04:10 PM
Madaus Martin D	Director	Nov 19 '24	Buy	40.77	4,940	201,404	7,405	Nov 19 04:00 PM
Cueto Herman	EVP, Chief Financial Officer	Oct 17 '24	Sale	43.68	1,595	69,670	24,604	Oct 21 04:10 PM
JASON JOSEPH	Officer	Aug 01 '24	Proposed Sale	62.05	1,000	62,050		Aug 01 04:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZTA

Azenta Inc

Upgrade your FINVIZ experience